IGF1 and tuberculosis: We could start at looking at our IGF [internally generated funds]; what we could do with it so if we have a lab that is just looking at TB maybe we could say that let’s expand it and look at other laboratory things and generate some funding for it so that the returns from these ones will now go into the vulnerable diseases.